Global Medical Marijuana Market 2021 Expeditious Growth, Opportunities and forecast to 2030


Posted October 6, 2021 by Vaibhavwa_mrfr21

AbsoluteMarketInsights Presents “Medical Marijuana Market Research Report –Global Forecast to 2030” New Document to its Studies Database

 
Medical Marijuana Market 2021

COVID 19- Update: Medical Marijuana Market was Estimated to be US$ 16.86 Bn in 2018 and is Expected grow at a CAGR of 20.55% Over the Forecast Period; says Absolute Markets Insights

Medical Marijuana Market Owing To the Increasing Demand for Marijuana-Based Medicines among End-Users as a Result of Economic Prices

The use of cannabis as a medicine has been a widely debated topic among the global audience. Though the unrestricted use of marijuana can have detrimental impacts on the immune and respiratory system, proponents of marijuana-derived medicines believe that synthesis of cannabis strain in non-lethal proportions can cure ailments such as arthritis, chronic and acute pain and loss of appetite, amongst others. It has been proved that the cannabis plant is infused with approximately 700 different types of chemicals. In this, the number of cannabinoids is around 100.

Access Full Report Details and Order this Premium Report @ https://www.absolutemarketsinsights.com/reports/Medical-Marijuana-Market-2019-2027-554

Major Key Players:

Some of the players operating in the medical marijuana market are Abattis Bioceuticals Corp., Agripharm Corp., Aurora Cannabis Enterprises Inc.,Cannabis Sativa, Inc., CannaGrow Holdings, Inc., Canopy Growth Corporation, Cara Therapeutics, Inc, Cresco Labs, LLC, Emerald Health Botanicals Inc. , Growblox Sciences, Inc., GW Pharmaceuticals plc, Insys Therapeutics, Inc.. , Lexaria Corp., Medical Marijuana Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceuticals USA, Inc.,Tweed Inc.,United Cannabis Corporation and Whistler Medical Marijuana Corp, amongst others.

Key findings of the report:

Based on the application, pain management accounted for the highest share in global medical marijuana market in 2018. The economic prices of marijuana medicines coupled with the reduced side effects is propelling this growth.

Based on distribution channels, pharmacies account for the highest share in the global medical marijuana market. The ease of distribution through licensed pharmacies is a major reason for this.

As far as geography is concerned, North America accounted for maximum share in the global medical marijuana market in 2018. This can be attributed to the liberal laws in Canada and several U.S. states and the presence of prominent marijuana producers with cutting edge technology in the region.

Market Segmentation

By Application

Pain Management

Neuropathic

Inflammatory

Neurological Health Management

Sclerosis

Epilepsy

Alzheimer’s Disease

Parkinson’s Disease

Huntington’s Disease

Other Diseases

Mental Health Management

Post Traumatic Stress Disorder (PTSD)

Depression

Anxiety

ADHD

Others

Others

By Distribution Channel

Pharmacies

Hospitals and Dispensaries

Online Retailers

By Type

Indica

Sativa

Hybrid

By Form

Capsule

Spray

Oil

Others

By Geography

North America

U.S

Canada

Mexico

Rest of North America

Europe

UK

Germany

Italy

Switzerland

Nordic Countries

Denmark

Finland

Norway

Benelux Union

Belgium

The Netherlands

Luxembourg

Rest of Europe

Asia Pacific

New Zealand

Australia

South Korea

Southeast Asia

Thailand

Malaysia

Rest of Southeast Asia

Rest of Asia Pacific

Middle East and Africa

Israel

Zimbabwe

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Uruguay

Rest of Latin America

Contact us:

Shreyas Tanna

Phone: +91-740-024-2424

Absolute Markets Insights

Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By AMI
Country India
Categories Health
Tags Medical Marijuana Market
Last Updated October 6, 2021